Purification of Filamentous Bacteriophage for Phage Display Using Size-Exclusion Chromatography

MY Zakharova,AV Kozyr,AN Ignatova,IA Vinnikov,IG Sherriyakin,AV Kolesnikov

DOI: https://doi.org/10.2144/05382bm04

2005-01-01

Abstract:BioTechniquesVol. 38, No. 2 BenchmarksOpen AccessPurification of filamentous bacteriophage for phage display using size-exclusion chromatographyMaria Yu. Zakharova, Arina V. Kozyr, Anna N. Ignatova, Ilya A. Vinnikov, Igor G. Shemyakin & Alexander V. KolesnikovMaria Yu. ZakharovaRussian Academy of Sciences, Moscow, Arina V. KozyrRussian Academy of Sciences, Moscow, Anna N. IgnatovaRussian Academy of Sciences, Moscow, Ilya A. VinnikovRussian Academy of Sciences, Moscow, Igor G. ShemyakinState Research Center for Applied Microbiology, Obolensk, Russia & Alexander V. Kolesnikov*Address correspondence to: Alexander V. Kolesnikov, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Ul. Miklukho-Maklaya, 16/10, 117997 GSP, Moscow V-437, Russia. e-mail: E-mail Address: koleso@ibch.ruRussian Academy of Sciences, MoscowPublished Online:30 May 2018https://doi.org/10.2144/05382BM04AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail Phage display has proved itself as a powerful and convenient approach for rapid sampling of billions of proteinaceous structures against a ligand of interest. The most widespread system uses display of proteins and peptides as fusions to coat proteins III or VIII of the M13/fd phage. Efficient screening of phage display library requires high purity of the input phage particles.Double precipitation by polyethylene glycol (PEG) with an average molecular weight of 8000 Da (PEG-8000) is a standard technique for purification of filamentous bacteriophages (1,2). Certain contaminants could still remain in the PEG-purified phage preparation. Although efficient removal of contaminating RNases from bacteriophage preparation using treatment by ionic detergent followed by ultracentrifugation in CsCl gradient was reported (3), this method is costly, time-consuming, and is not applicable if the native state of the phage-displayed protein or peptide is affected by ionic detergents and high salt.Size-exclusion chromatography (SEC) has been used in preparation of pure eukaryotic viruses (4,5) and bacteriophage λ (6). We assumed that SEC can be the method of choice for efficient purification of filamentous phages under mild conditions. In this work we describe a rapid and simple technique for chromatographic purification of filamentous phage particles in Sephacryl™ S-500 resin (Amersham Biosciences, Piscataway, NJ, USA).The purity of phage preparations obtained after double PEG precipitation was assayed by electrophoresis in Tris-tricine (7). Phage particles displayed the single-chain variable fragment (scFv) of the MRL-4 anti-DNA monoclonal antibody (MAb) (8) fused to the C-terminal portion of the pIII minor phage coat protein (δpIII). Production of the scFv-δpIII fusion cloned into the pTScDisp phagemid (GenBank® accession no. AY618909) was controlled by the tac promoter. The phagemid was grown in the DH12S Escherichia coli strain (Invitrogen, Carlsbad, CA, USA) induced to express the scFv-δpIII by the addition of 0.1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and rescued by the VCS M13 helper phage using the standard technique (2). The same phagemid was grown and rescued without induction of the scFv-δpIII expression in the presence of 2% glucose instead of IPTG. Purification of phage particles was done using the standard protocol (1,2), except the first PEG precipitate was resuspended in phosphate-buffered saline (PBS) containing 0.05% Tween® 20. Purified particles were stored in PBS at 4°C until use. After purification, plaque- and colony-forming units per milliliter (pfu/mL and cfu/mL, respectively) were quantitated as described previously (2).Approximately 5×1011 pfu of PEG-purified phage particles were mixed 1:1 with the sample loading buffer, boiled for 5 min, electrophoresed, and then the gel was silver-stained. The assay, done in triplicate, showed that phage preparations contained varying amounts of proteinaceous and low-molecular weight impurities. A particularly high level of contaminants was observed at the background of the induced expression of the scFv-δpIII fusion (Figure 1, lane 2).Figure 1. Denaturing Tris-tricine electrophoresis of purified phage particles obtained after rescue of a phagemid displayed the single-chain variable fragment (scFv)-p3 fusion.Lane 1, phage preparation recovered after size-exclusion chromatography (SEC). The major band is the phage coat protein pVIII, molecular weight 6 kDa; lane 2, same preparation but purified by double-polyethylene glycol (PEG) precipitation only; lane 3, low molecular weight (LMW) marker (Amersham Biosciences).PEG-purified phages were subjected to the SEC in Sephacryl S-500 resin. The exclusion limit of Sephacryl S-500 (2×107 Da) is well suited for separation of filamentous phage particles (approximate molecular weight of 17×107 Da) from a wide range of potential contaminants. A sample containing 1013 pfu in 0.5 mL PBS was loaded onto the Superdex™ 200 HR 10/30 column (Amersham Biosciences) packed with 30 mL of Sephacryl S-500 resin and pre-equilibrated with PBS. Since the typical pfu/cfu ratio was 99:1, only pfus were considered in the calculation of total amount of loaded particles. The optimal amount of the phage preparation that could be loaded to the column without loss of separation efficiency was determined experimentally (data not shown). The column was developed with PBS at 0.4 mL/min using a chromatography system equipped by the Model 994 photodiode array detector (Waters, Milford, MA, USA) set at 280 nm.The 1-mL fractions of the column eluate were collected and assayed for pfu and cfu counts. The elution profile consisted of two peaks (Figure 2). Most of the phage particles were eluted in the first peak (4.5 mL total volume), whereas other fractions contained at least 5 orders of magnitude less phages. The second peak contained various contaminants and PEG. Loss of the phage and phagemid viability after SEC was about 10% judging by comparison of pfu and cfu counts obtained before and after chromatography. In some experiments SEC-purified phage particles were concentrated using Centricon®-100 (Millipore, Billerica, MA, USA) without loss of infectivity. In total, the chromatographic purification took 20 min to collect the eluted phage, or 1-1.5 h if the sample concentration was performed.Figure 2. Elution profile of phage preparation subjected to the size-exclusion chromatography (SEC) with Sephacryl S-500.An aliquot of SEC-purified phage preparation contained 5×1011 pfu was electrophoretically resolved (7) (Figure 1). Silver staining of the gel revealed single major band corresponding to the pVIII coat protein and faint bands possibly belonging to other phage proteins (Figure 1, lane 1). After SEC, the impurities observed in the PEG-purified phage preparation (Figure 1, lane 2) were efficiently removed.After demonstrating that SEC did not significantly decrease phage viability, we asked if chromatographic purification could reduce panning efficiency by increased shedding of the displayed moiety. The panning efficiency of the SEC-purified phage particles was assayed in three different formats: (i) δpIII-based peptide display; (ii) pVIII-based peptide display; and (iii) δpIII-protein display. In all the formats, panning of the phage particles was achieved by using the c-myc peptide tether and the anti-c-myc 9E10 MAb (accession no. CRL-1729; ATCC, Manassas, VA, USA). The construct expressing the c-myc-δpIII fusion was prepared by PCR-mediated insertion of the c-myc DNA in the pTDisp vector (GenBank accession no. AY618908) between pelB and δgIII sequences. The construct for display of the protein-δpIII fusion was prepared by inserting the DNA encoded the VIPase catalytic antibody light chain with N-terminal c-myc and His6 tags, pelB leader sequence, and ribosome-binding site (RBS) (9) in pTDisp. The construct encoded the c-myc-pVIII fusion was assembled by PCR and cloned into the pTDisp in place of δgIII. Each of the constructs was used to produce c-myc positive (c-myc+) phagemid particles. The c-myc negative (c-myc-) particles were prepared by rescuing the unmodified pTScDisp with VCS M13. After PEG-purification and quantitation, equal amounts of cfu displaying each of the three fusions were mixed with the c-myc- particles at the 1:100 dilution ratios. Half of each mixed pool was purified by SEC and analyzed for cfu/pfu counts. Judging by electrophoretic analysis, the contaminants found in all the PEG-purified preparations were removed by the SEC (data not shown).For panning, 109 cfu/0.5 mL from each of the pools were incubated with 100 µg of 9E10 MAb for 2 h, than mixed with 100 µL of Protein G Sepharose® (Amersham Biosciences) and incubated for the next 2 h. The unbound particles were removed by repeated washing with PBS, and then bound phages were eluted from the Sepharose with glycine-HCl, pH 2.6, and used to infect E. coli. Infected bacteria were plated, and individual ampicillin-resistant colonies were analyzed by PCR for the presence of the c-myc+ construct.In each of the display formats analyzed, similar panning efficiency was observed for PEG/SEC-purified and PEG-purified phagemid preparations. For the c-myc-δpIII display, 18/100 c-myc+ clones were captured from the SEC-purified pool, and 19/100 clones from the PEG-purified one in single round. For a single round of c-myc-pVIII phagemid panning, the respective values were 41/100 and 37/100 of c-myc+ clones. Two rounds of panning were required to achieve detectable enrichment of VIPase-displaying phages. After a second round of panning, 11/100 c-myc+ clones were captured from the SEC-purified pool, and 9/100 from the PEG-purified one. Use of SEC did not affect the panning efficiency in the three display formats analyzed. The quantity of phage particles purified at the 30-mL column in a single run (1013) exceeds the size of the largest reported phage display libraries by 2 orders of magnitude and is sufficient for conducting the panning round. If necessary, the procedure can be scaled up using larger columns.Modifications of the "classic" phage display, such as the in vitro evolution of enzymatic activity, selection of phages internalizing into eukaryotic cells, and the "substrate phage" technique (see Reference 1 for a review), demand high purity of phage(mid) preparations. Certain enzymes co-precipitating with phages hamper selection of phage-displayed catalytic activity (3). The E. coli lipopolysaccharide (LPS) and the traces of PEG that remained in the sample could be cytotoxic and thus impeding phage panning utilizing living eukaryotic cells. The contaminants in the phage samples could also interfere with phage enzyme-linked immunosorbent assay (ELISA) employing highly reactive phosphonates (10) and chloromethyl ketones (11) as the probes. The SEC-based method of purification of phage particles is fast and reproducible and yields highly pure phage preparation while preserving the phage infectivity and the integrity of displayed moieties.In summary, we developed a method by which contaminants observed in the PEG-purified phage preparations can be removed under mild conditions. We hope that the new technique could be useful in various applications of the phage display library approach.AcknowledgmentsThe work was supported by the Russian Foundation of Basic Research (grant no. 02-04-49411) and by International Science and Technology Center (grant no.1758).Competing Interests StatementThe authors declare no competing interests.References1. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. CSH Laboratory Press, Cold Spring Harbor, NY.Google Scholar2. Kay, B.K., J. Winter, and J. McCafferty. 1996. Phage Display of Peptides and Proteins. A Laboratory Manual. Academic Press, San Diego.Google Scholar3. Korn, K., H.H. Foerster, and U. Hahn. 2000. Phage display of RNase A and an improved method for purification of phages displaying Rnases. Biol. Chem. 381:179–181.Crossref, Medline, CAS, Google Scholar4. Loa, C.C., T.L. Lin, C.C. Wu, T.A. Bryan, H.L. Thacker, T. Hooper, and D. Schrader. 2002. Purification of turkey coronavirus by Sephacryl size-exclusion chromatography. J. Virol. Methods 104:187–194.Crossref, Medline, CAS, Google Scholar5. Transfiguracion, J., D.E. Jaalouk, K. Ghani, J. Galipeau, and A. Kamen. 2003. Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Hum. Gene Ther. 14:1139–1153.Crossref, Medline, CAS, Google Scholar6. Sain, B. and S. Erdei. 1981. Bacteriophage purification by gel chromatography. Anal. Biochem. 110:128–130.Crossref, Medline, CAS, Google Scholar7. Schagger, H. and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368–379.Crossref, Medline, CAS, Google Scholar8. Kofler, R., R. Strohal, R.S. Balderas, M.E. Johnson, D.J. Noonan, M.A. Duchosal, F.J. Dixon, and A.N. Theofilopoulos. 1988. Immunoglobulin kappa light chain variable region gene complex organization and immunoglobulin genes encoding anti-DNA autoantibodies in lupus mice. J. Clin. Invest. 82:852–860.Crossref, Medline, CAS, Google Scholar9. Demin, A.V., A.V. Kolesnikov, M.A. Olfer'ev, P.V. Favorov, K.V. Fegeding, A.G. Gabibov, and N.V. Gnuchev. 1998. Design of constructions for the expression of proteolytic antibody light chain. Genetika 34:1333–1337.Medline, CAS, Google Scholar10. Gao, C., C.H. Lin, C.H. Lo, S. Mao, P. Wirsching, R.A. Lerner, and K.D. Janda. 1997. Making chemistry selectable by linking it to infectivity. Proc. Natl. Acad. Sci. USA 94:11777–11782.Crossref, Medline, CAS, Google Scholar11. Atwell, S. and J.A. Wells. 1999. Selection for improved subtiligases by phage display. Proc. Natl. Acad. Sci. USA 96:9497–9502.Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByManufacturing of bacteriophages for therapeutic applicationsBiotechnology Advances, Vol. 49Standard Bacteriophage Purification Procedures Cause Loss in Numbers and Activity20 February 2021 | Viruses, Vol. 13, No. 2Bacteriophage Manufacturing: From Early Twentieth-Century Processes to Current GMP31 January 2021Improvements in the production of purified M13 bacteriophage bio-nanoparticle29 October 2020 | Scientific Reports, Vol. 10, No. 1Comparative Analysis of Blood and Marrow Cellular Structure of White Mice Infected With Bacillus Anthracis Different Genotypes17 March 2020 | Acta Biomedica Scientifica (East Siberian Biomedical Journal), Vol. 5, No. 1Bacteriophage Manufacturing: From Early Twentieth-Century Processes to Current GMP10 February 2018Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections10 November 2016 | Expert Opinion on Drug Delivery, Vol. 14, No. 8Antibody Phage Display17 March 2018Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold4 August 2015 | Frontiers in Microbiology, Vol. 6Targeting glioblastoma via intranasal administration of Ff bacteriophages27 May 2015 | Frontiers in Microbiology, Vol. 06Adsorption and Self-Assembly of M13 Phage into Directionally Organized Structures on C and SiO 2 Films18 September 2014 | Langmuir, Vol. 30, No. 38Nanomesh-Structured Ultrathin Membranes Harnessing the Unidirectional Alignment of Viruses on a Graphene-Oxide Film20 March 2014 | Advanced Materials, Vol. 26, No. 23Construction and analysis of a genetically tuneable lytic phage display system3 May 2013 | Applied Microbiology and Biotechnology, Vol. 97, No. 17A simple and rapid method to isolate purer M13 phage by isoelectric precipitation27 June 2013 | Applied Microbiology and Biotechnology, Vol. 97, No. 18Wie man DNA aufspürtTherapeutic Potential of Staphylococcal Bacteriophages for Nasal Decolonization of Staphylococcus aureus in MiceAdvances in Microbiology, Vol. 03, No. 01Purification and quantitation of bacteriophage M13 using desalting spin columns and digital PCRJournal of Virological Methods, Vol. 185, No. 1Bacteriophage based probes for pathogen detectionThe Analyst, Vol. 137, No. 15Surface-immobilization of chromatographically purified bacteriophages for the optimized capture of bacteria22 October 2014 | Bacteriophage, Vol. 2, No. 1Phage Display: Selecting Straws Instead of a Needle from a Haystack19 January 2011 | Molecules, Vol. 16, No. 1Hydroxyapatite chromatography of phage-display virionsGeorge P. Smith & Todd R. Gingrich30 May 2018 | BioTechniques, Vol. 39, No. 6 Vol. 38, No. 2 Follow us on social media for the latest updates Metrics History Received 29 January 2004 Accepted 8 September 2004 Published online 30 May 2018 Published in print February 2005 Information© 2005 Author(s)AcknowledgmentsThe work was supported by the Russian Foundation of Basic Research (grant no. 02-04-49411) and by International Science and Technology Center (grant no.1758).Competing Interests StatementThe authors declare no competing interests.PDF download